Skip to content

Effect of Pre-emptive Dose of Prednisone Versus Placebo in Impacted Third Molar Surgery

Three-dimensional Facial Swelling Evaluation of Pre-operative Single-dose of Prednisone in Third Molar Surgery: a Split-mouth Randomized Controlled Trial

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05830747
Enrollment
34
Registered
2023-04-26
Start date
2022-02-01
Completion date
2022-12-10
Last updated
2023-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Facial Swelling, Tooth Avulsion, Tooth Extraction Status Nos, Tooth, Impacted, Tooth Position Anomalies

Keywords

third molar surgery, facial swelling, 3D facial swelling evaluation, tooth impacted, prednisone drug administration, corticosteroids administration

Brief summary

The present study proposes to compare the effect of a single preoperative dose of prednisone versus placebo in terms of facial swelling, trismus and pain after surgical removal of the mandibular third molar (M3M) in a split-mouth randomized controlled clinical trial.

Detailed description

This study aims to compare the effect of a single preoperative dose of prednisone versus placebo in terms of facial swelling, trismus, and pain after surgical removal of M3M in a split-mouth randomized controlled clinical trial. Facial swelling will be evaluated using an innovative three-dimensional digital technique.

Interventions

DRUGPrednisone

Pre-operative drug administration before third molar surgery

DRUGPlacebo

Pre-operative Placebo administration before third molar surgery

Sponsors

University Magna Graecia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 32 Years
Healthy volunteers
Yes

Inclusion criteria

* Patients aged 18 to 32 years who required both M3M extractions were recruited * Good health status * Indication to surgical extraction of both M3M * Complete root formation * Surgical risk level classified as Conventional or Moderate according to Daugela et al. classification

Exclusion criteria

* Person under the age of 18 or over 32 * Allergy or contraindications to administration of corticosteroids * Acute infection in any of the teeth to be extracted * Patients with chronic liver disease, diabetes, immune system dysfunction, or haematological disease * Pregnancy or breastfeeding * History of treatment with antiresorptive drugs * Chronic kidney disease * History of systemic corticosteroid therapy in the past 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
Change in facial swellingChange from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo compare the effectiveness of prednisone/os versus placebo in reducing facial swelling using qualitative three-dimensional analysis (measured by colorimetric variation given by the overlapping volumes) .

Secondary

MeasureTime frameDescription
Change in trismusChange from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo assess the effects of prednisone/os administration on trismus (measured in cm)
Change in pain with Visual analogue scale (VAS)Change from baseline (before surgery) at 2 day after surgery and at 7 days after surgeryTo assess the effects of prednisone/os administration on pain (measured by VAS-score from 0 to 10 point, with 10 as the worst outcome)

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026